Cardlytics Inc. (CDLX)
Cardlytics Statistics
Share Statistics
Cardlytics has 52.17M shares outstanding. The number of shares has increased by 6.77% in one year.
| Shares Outstanding | 52.17M |
| Shares Change (YoY) | 6.77% |
| Shares Change (QoQ) | 2.48% |
| Owned by Institutions (%) | 60.62% |
| Shares Floating | 49.56M |
| Failed to Deliver (FTD) Shares | 795 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 8.16M, so 15.67% of the outstanding shares have been sold short.
| Short Interest | 8.16M |
| Short % of Shares Out | 15.67% |
| Short % of Float | 18.65% |
| Short Ratio (days to cover) | 10.16 |
Valuation Ratios
The PE ratio is -0.95 and the forward PE ratio is -1.1. Cardlytics's PEG ratio is -0.16.
| PE Ratio | -0.95 |
| Forward PE | -1.1 |
| PS Ratio | 0.64 |
| Forward PS | 0.2 |
| PB Ratio | 2.56 |
| P/FCF Ratio | -20.33 |
| PEG Ratio | -0.16 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardlytics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.17.
| Current Ratio | 1.19 |
| Quick Ratio | 1.19 |
| Debt / Equity | 3.17 |
| Debt / EBITDA | -1.45 |
| Debt / FCF | -25.12 |
| Interest Coverage | -21.96 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $612.99K |
| Profits Per Employee | $-416.97K |
| Employee Count | 454 |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -87.73% in the last 52 weeks. The beta is 1.4, so Cardlytics's price volatility has been higher than the market average.
| Beta | 1.4 |
| 52-Week Price Change | -87.73% |
| 50-Day Moving Average | 2.3 |
| 200-Day Moving Average | 3.92 |
| Relative Strength Index (RSI) | 38.5 |
| Average Volume (20 Days) | 1.06M |
Income Statement
In the last 12 months, Cardlytics had revenue of 278.3M and earned -189.3M in profits. Earnings per share was -3.91.
| Revenue | 278.3M |
| Gross Profit | 120.89M |
| Operating Income | -195.5M |
| Net Income | -189.3M |
| EBITDA | -152.53M |
| EBIT | -180.4M |
| Earnings Per Share (EPS) | -3.91 |
Balance Sheet
The company has 65.59M in cash and 221.65M in debt, giving a net cash position of -156.06M.
| Cash & Cash Equivalents | 65.59M |
| Total Debt | 221.65M |
| Net Cash | -156.06M |
| Retained Earnings | -1.3B |
| Total Assets | 392.71M |
| Working Capital | 29.03M |
Cash Flow
In the last 12 months, operating cash flow was -8.82M and capital expenditures 0, giving a free cash flow of -8.82M.
| Operating Cash Flow | -8.82M |
| Capital Expenditures | 0 |
| Free Cash Flow | -8.82M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 43.44%, with operating and profit margins of -70.25% and -68.02%.
| Gross Margin | 43.44% |
| Operating Margin | -70.25% |
| Pretax Margin | -68.02% |
| Profit Margin | -68.02% |
| EBITDA Margin | -54.81% |
| EBIT Margin | -70.25% |
| FCF Margin | -3.17% |
Dividends & Yields
CDLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CDLX is $3.25, which is 116.7% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.25 |
| Price Target Difference | 116.7% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Scores
| Altman Z-Score | -5.23 |
| Piotroski F-Score | 3 |